Contact this trialFirst, we need to learn more about you.
Dopamine D1 Receptor Antagonist
Ecopipam for Tourette Syndrome
Recruiting1 awardPhase 2
Bellaire, Texas
This trial tested the safety of ecopipam tablets for children and adolescents with Tourette Syndrome. The medication aims to help manage their symptoms by affecting brain chemicals. Participants took the medication for an extended period with frequent check-ups. Ecopipam has shown promise in previous studies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service